Invest in

Fighting Fat

21.8%
9.4%
0.8%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
21.8%
9.4%
0.8%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
48.9% Diabetes Care 10.2%
16.0% Merck & Company Inc. (new) MRK 22.9%
14.8% Sanofi SNY 19.4%
11.0% Novo Nordisk A/S NVO 36.3%
2.7% Astrazeneca Plc ADR AZN 17.0%
2.3% Alkermes plc ALKS 86.1%
2.1% Integer Holdings Corporation ITGR --
45.3% Weight Management 118.2%
25.1% NutriSystem Inc NTRI 188.8%
8.6% MEDIFAST INC MED 52.0%
4.7% Weight Watchers International Inc WTW 14.4%
3.4% Nu Skin Enterprises Inc. (A) NUS 51.5%
1.8% USANA Health Sciences Inc. USNA 2.3%
1.2% Vitamin Shoppe Inc VSI 35.3%
0.5% GNC Holdings Inc. Class A GNC 76.3%
5.8% Weight Loss Drugs 20.8%
5.8% Arena Pharmaceuticals Inc. ARNA 20.8%

Quotes delayed 15 mins. Currently Mar 25, 2017 7:37:58 PM. Fields are marked with -- when data is unavailable.